Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Seizure Alert: An Interdisciplinary Protocol for Timely Anti-Seizure Medication Administration in the Setting of Status Epilepticus
Practice, Policy, and Ethics
P3 - Poster Session 3 (5:30 PM-6:30 PM)
1-004

Status epilepticus (SE) is an emergency associated with high morbidity and mortality. Between 50,000 and 150,000 Americans each year have SE, with mortality after the first episode estimated at 16-20%. Data has shown that delays in time to administration of first and subsequently second line agents significantly increased morbidity, mortality, and length of stay of hospitalized patients.


Through a quality improvement project, our team sought to implement an interdepartmental seizure alert protocol, where medication and resources can be deployed to ensure timely ASM administration.

Healthcare providers may activate a seizure alert by calling the operator, who then pages the neurology resident and pharmacy, with a message reading “code seizure” including the patient’s location. Responders can work collaboratively at bedside to coordinate administration of first and second line ASM if warranted. Pharmacy will have a pre-packaged kit of second line ASMs that can be rapidly deployed to the patient location. The physician and pharmacist at bedside can work together to determine the appropriate ASM. Educational sessions for nursing and pharmacy were held prior to implementation of the protocol.


In seizures which presented as stroke mimics (pre-intervention data) where a stroke alert was activated (n=39), time of stroke alert activation to the ASM load took an average of 112 minutes. In those patients where seizure alert (post-intervention) was activated (n=9), time to second-line ASM load from alert activation took an average of 87 minutes. Future analysis will be aimed at group comparisons via histograms and parametric tests with independently paired t-tests.

Our goal was to implement a seizure alert protocol in order to streamline patient care and improve time to second-line ASM administration. We are continuing to collect post-intervention data which may have important implications in the interdisciplinary bedside assessment and treatment of patients with suspected SE.


Authors/Disclosures
Kelly L. Block, DO
PRESENTER
Dr. Block has nothing to disclose.
Lauren C. Skalomenos, MD (UT San Antonio) Dr. Skalomenos has nothing to disclose.
Joanna J. Chang, MD Dr. Chang has nothing to disclose.
Shaun O. Smart, MD Dr. Smart has nothing to disclose.